1. Home
  2. GNFT vs HOND Comparison

GNFT vs HOND Comparison

Compare GNFT & HOND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GNFT
  • HOND
  • Stock Information
  • Founded
  • GNFT 1999
  • HOND 2024
  • Country
  • GNFT France
  • HOND United States
  • Employees
  • GNFT N/A
  • HOND N/A
  • Industry
  • GNFT Biotechnology: Biological Products (No Diagnostic Substances)
  • HOND
  • Sector
  • GNFT Health Care
  • HOND
  • Exchange
  • GNFT Nasdaq
  • HOND NYSE
  • Market Cap
  • GNFT 190.6M
  • HOND 287.8M
  • IPO Year
  • GNFT 2019
  • HOND 2024
  • Fundamental
  • Price
  • GNFT $3.71
  • HOND $10.01
  • Analyst Decision
  • GNFT Strong Buy
  • HOND
  • Analyst Count
  • GNFT 1
  • HOND 0
  • Target Price
  • GNFT $13.00
  • HOND N/A
  • AVG Volume (30 Days)
  • GNFT 7.9K
  • HOND 1.1K
  • Earning Date
  • GNFT 09-19-2024
  • HOND 01-01-0001
  • Dividend Yield
  • GNFT N/A
  • HOND N/A
  • EPS Growth
  • GNFT N/A
  • HOND N/A
  • EPS
  • GNFT 0.47
  • HOND N/A
  • Revenue
  • GNFT $86,225,222.00
  • HOND N/A
  • Revenue This Year
  • GNFT $155.44
  • HOND N/A
  • Revenue Next Year
  • GNFT N/A
  • HOND N/A
  • P/E Ratio
  • GNFT $7.55
  • HOND N/A
  • Revenue Growth
  • GNFT 175.45
  • HOND N/A
  • 52 Week Low
  • GNFT $3.31
  • HOND $9.97
  • 52 Week High
  • GNFT $6.42
  • HOND $11.57
  • Technical
  • Relative Strength Index (RSI)
  • GNFT 33.06
  • HOND N/A
  • Support Level
  • GNFT $3.63
  • HOND N/A
  • Resistance Level
  • GNFT $3.94
  • HOND N/A
  • Average True Range (ATR)
  • GNFT 0.13
  • HOND 0.00
  • MACD
  • GNFT 0.03
  • HOND 0.00
  • Stochastic Oscillator
  • GNFT 19.17
  • HOND 0.00

About GNFT GENFIT S.A.

Genfit SA is a biotechnology company focused on metabolic and inflammatory diseases, with a particular focus on the liver and gastroenterology. The company's research and development activity relies on its expertise in modulating gene expression through nuclear receptors. Genfit utilizes acquisitions, strategic alliances, and licensing agreements in order to fund the further development of its products. It has one segment the research and development of innovative medicines and diagnostic solutions, the marketing of which depends on the success of the clinical development phase.

About HOND HCM II ACQUISITION CORP

HCM II Acquisition Corp is a blank check company.

Share on Social Networks: